fda approval of tirzepatide for weight loss GROUNDBREAKING UPDATE! has approved TIRZEPATIDE, a pioneering obesity treatment activating GIP & GLP-1 receptors, loss! Previously, has been FDA approved for type 2 diabetes as Mounjaro, and although Eli Lilly seeks FDA approval

In clinical trials, only about 3% of those treated with 2.4 mg of semaglutide experienced the side effect

Curcumin reduces Streptococcus mutans biofilm formation by inhibiting sortase A activity

o Abdominal pain: Often related to slowed gastric emptying

Unlike phentermine's fixed short-term window, semaglutide allows continuous treatment for months or years, making long-term weight loss maintenance possible

Metformin protects against insulin resistance induced by high uric acid in cardiomyocytes via AMPK signalling pathways in vitro and in vivo

Mysterious polar weather on Jupiter and Saturn could be key to understanding their insides "I don't think anyone's made this connection between the surface fluid pattern and the interior properties of these planets." Scientists may finally know why Jupiter and Saturn have very different weather patterns at their poles, despite having similar sizes and compositions